Can I Take Folate with Trazodone?

What the Evidence Says About Folate and Trazodone Together

No controlled trial has demonstrated a direct pharmacokinetic interaction between folate and trazodone. The two compounds operate through entirely separate pathways: trazodone blocks serotonin reuptake and antagonizes 5-HT2A receptors, while folate serves as a one-carbon donor in the methylation cycle that produces neurotransmitter precursors [1, 2]. Because their mechanisms do not converge at shared metabolic enzymes or plasma-protein binding sites, combining them does not alter the blood levels of either compound.

Clinically, the relevant question is not whether folate interferes with trazodone, but whether folate status affects overall antidepressant response in people who take serotonergic drugs.

How Trazodone Works

Trazodone is classified as a serotonin antagonist and reuptake inhibitor (SARI). At doses of 25 to 150 mg used for insomnia, its primary effect is antagonism at histamine H1 and alpha-1 adrenergic receptors, producing sedation [3]. At the antidepressant dose range of 150 to 400 mg per day, trazodone also inhibits the serotonin transporter (SERT), raising synaptic serotonin. The drug is metabolized mainly by CYP3A4 to an active metabolite, meta-chlorophenylpiperazine (mCPP) [3].

How Folate Fits Into Brain Chemistry

Folate, as 5-methyltetrahydrofolate (5-MTHF), donates a methyl group to homocysteine, regenerating methionine and ultimately S-adenosylmethionine (SAM). SAM is the universal methyl donor for the synthesis of serotonin, dopamine, and norepinephrine [4]. Low folate therefore reduces SAM availability, which may blunt monoamine synthesis and reduce the substrate on which drugs like trazodone act [4]. A 1997 meta-analysis by Alpert and Fava found that low serum folate was associated with poorer antidepressant response across multiple drug classes [5].

Is Folate Safe to Take with Trazodone?

Yes. No interaction database, including the Natural Medicines Comprehensive Database and the FDA's MedWatch system, lists folate as contraindicated or even cautioned with trazodone. The combination carries no known risk of serotonin syndrome, QTc prolongation, sedation potentiation, or altered drug metabolism [1].

Pharmacokinetic Safety

Trazodone's CYP3A4-dependent metabolism is not inhibited or induced by folate at any dietary or supplemental dose studied to date [3]. Plasma protein binding of trazodone (approximately 89 to 95%) is also unaffected by folate [3]. Standard folate supplements (400 mcg to 1 mg folic acid) produce serum folate concentrations far below any threshold that would alter hepatic enzyme activity.

Pharmacodynamic Considerations

Both trazodone and folate support serotonergic neurotransmission, but through different rate-limiting steps. This additive effect on mood is generally considered beneficial, not harmful. There is no evidence that supra-physiologic folate supplementation produces serotonin excess or toxicity when combined with a SARI like trazodone [4].

The MTHFR Connection

The MTHFR gene encodes methylenetetrahydrofolate reductase, the enzyme that converts dietary folate into its active form, 5-MTHF. Two common variants, C677T and A1298C, reduce enzyme activity [6]. The homozygous C677T (TT) genotype reduces MTHFR activity by approximately 70%, meaning carriers convert far less dietary folic acid into usable 5-MTHF [6].

Why MTHFR Matters for Depression

Reduced MTHFR activity raises homocysteine and lowers SAM, both of which associate with depressive symptoms and worse antidepressant outcomes [6]. A 2008 analysis in the American Journal of Psychiatry found that MTHFR C677T TT homozygotes had significantly higher homocysteine and lower response rates to antidepressants compared to CC genotype carriers [7].

L-Methylfolate as the Solution

L-methylfolate (brand names Deplin, EnLyte) provides 5-MTHF directly, bypassing the MTHFR enzyme entirely. The FDA-cleared medical food Deplin is available at 7.5 mg and 15 mg doses. A 2012 randomized controlled trial by Papakostas et al. (N=75) showed that adding L-methylfolate 15 mg/day to an SSRI produced a response rate of 32.3% versus 14.6% for placebo augmentation (P<0.05), and the benefit was largest in patients with low baseline folate and biomarkers of impaired methylation [8]. Although that trial used SSRIs rather than trazodone specifically, the underlying mechanism, improving SAM-dependent monoamine synthesis, applies equally to any serotonergic antidepressant.

Choosing Between Folic Acid and L-Methylfolate

For most adults without known MTHFR variants, standard folic acid at 400 to 800 mcg per day is adequate. For patients with confirmed MTHFR TT genotype, or with documented low serum folate despite dietary adequacy, L-methylfolate at 7.5 to 15 mg per day is the preferred form. Testing for MTHFR is available through standard clinical labs and is not required before supplementing, but it guides dose selection.

Folate Deficiency and Antidepressant Response

Low folate is more common than often recognized in adults taking psychiatric medications. Several anticonvulsants (phenytoin, valproate, carbamazepine) deplete folate through enzyme induction or direct folate antagonism [9]. Trazodone itself does not deplete folate. However, patients who take trazodone for comorbid depression and epilepsy, or who receive polypharmacy involving anticonvulsants, may have compounding reasons for folate deficiency.

Serum Folate as a Treatment Target

The American Psychiatric Association's 2010 Practice Guideline for Major Depressive Disorder notes that nutritional deficiencies, including folate, should be assessed in patients with treatment-resistant depression [10]. A serum folate below 2.5 ng/mL is generally considered deficient; below 5 ng/mL may still impair methylation in genetically susceptible individuals [5].

Homocysteine as a Proxy Marker

Elevated plasma homocysteine (above 15 micromol/L) signals functional folate or B12 insufficiency even when serum folate appears borderline normal [6]. Checking both markers together gives a more complete picture of methylation capacity before and during antidepressant therapy.

Dosing, Timing, and Practical Guidance

No dose-separation window is required between folate and trazodone. The two can be taken simultaneously or hours apart without any difference in efficacy or safety [1].

Recommended Doses by Indication

For general deficiency prevention, the Dietary Reference Intake for folate is 400 mcg per day for non-pregnant adults, rising to 600 mcg during pregnancy and 500 mcg during lactation [11]. For adjunct depression treatment in MTHFR-variant carriers, clinical trials have used L-methylfolate at 7.5 to 15 mg per day, well above the DRI but within a range showing no toxicity signals [8]. The tolerable upper intake level for folic acid (the synthetic form) is 1,000 mcg (1 mg) per day for adults, a limit set to prevent masking B12 deficiency rather than direct folate toxicity [11].

Practical Interaction Table

| Factor | Folic Acid (400 mcg, 1 mg) | L-Methylfolate (7.5 to 15 mg) | |---|---|---| | Interaction with trazodone | None known | None known | | MTHFR conversion needed | Yes | No | | Masks B12 deficiency | Possible at high doses | Less likely | | Cost | Low | Moderate to high | | Preferred population | General adults | MTHFR variants, treatment-resistant MDD |

When to Contact Your Prescriber

Tell your trazodone prescriber before starting high-dose L-methylfolate if you are also on lithium, MAOIs, or other serotonergic agents. Those combinations carry separate interaction concerns unrelated to folate itself. Also report any new neurological symptoms if you have undiagnosed B12 deficiency, because high-dose folate can correct the anemia of B12 deficiency while leaving neuropathy to progress [11].

Pregnancy, Folate, and Trazodone

Trazodone is FDA Pregnancy Category C (pre-2015 labeling), and its use in pregnancy is generally reserved for cases where benefit clearly outweighs risk. Folate supplementation in pregnancy is non-negotiable: the CDC and USPSTF both recommend 400 to 800 mcg of folic acid daily starting at least one month before conception to reduce neural tube defect risk by approximately 50 to 70% [12, 13]. Pregnant patients on trazodone should not reduce their folate intake out of concern for interaction. No teratogenic interaction between folic acid and trazodone has been reported in the literature.

The USPSTF states: "The USPSTF recommends that all women who are planning or capable of pregnancy take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid." [13]

Monitoring Recommendations

Baseline and follow-up labs are not mandatory when adding a standard dietary folate supplement to trazodone, but they are worth considering in specific situations.

Who Should Get Labs

Patients with suspected malabsorption (celiac disease, inflammatory bowel disease, bariatric surgery history) should have serum folate and B12 checked before starting any supplement. Patients on anticonvulsants co-prescribed with trazodone should have folate checked at baseline and every six to twelve months [9]. Anyone starting L-methylfolate at 15 mg per day for depression augmentation should have baseline serum folate, B12, and homocysteine documented.

Interpreting Results

• Serum folate below 2.5 ng/mL: frank deficiency, supplement regardless of trazodone use
• Serum folate 2.5 to 5.9 ng/mL: borderline; consider L-methylfolate if MTHFR TT genotype confirmed or antidepressant response is suboptimal
• Homocysteine above 15 micromol/L: functional deficiency, supplement with folate plus B12
• B12 below 200 pg/mL: treat B12 first before escalating folate dose [11]

What Clinicians Say About Folate Adjunct Therapy

Dr. David Mischoulon of Massachusetts General Hospital, one of the lead researchers in nutritional psychiatry, has written: "Folate augmentation is a rational strategy for patients with depressive disorders, particularly those with evidence of folate deficiency or MTHFR polymorphisms, given its favorable safety profile and mechanistic plausibility." [14]

The 2023 Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines on adjunctive treatments for MDD include folate among Level 3 evidence adjuncts, noting benefit signals in patients with low folate status [15].

Summary of Key Points

Taking folate with trazodone is safe. No pharmacokinetic interaction alters blood levels of either compound. Adequate folate status supports serotonin synthesis and may improve overall antidepressant outcomes. Patients with MTHFR C677T TT genotype should use L-methylfolate (7.5 to 15 mg/day) rather than folic acid to bypass impaired conversion. No dose-separation window is needed. Pregnant patients must maintain at least 400 to 800 mcg of folic acid daily regardless of trazodone use. Monitor serum folate and B12 in patients with malabsorption, anticonvulsant co-therapy, or treatment-resistant depression.